Senior insider sale
Chief Financial Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$11.20M
160K shares
What this filing means
MOKARI ATABAK plans to sell 160K shares of CORCEPT THERAPEUTICS INC valued at approximately $11.20M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/1/2026ACC: 0001972481-26-000177
Officer· Chief Financial Officer
Since Mar 2021
160K
Shares to sell
$11.20M
Approx. market value
160K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock Option Exercises
Equity Compensation
2/13/2023
64.17KStock Option Exercises
Equity Compensation
2/2/2022
95.83KTotal acquired160K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2023 | Stock Option Exercises Equity Compensation | 64.17K | — |
2/2/2022 | Stock Option Exercises Equity Compensation | 95.83K | — |
| Total | 160K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
160K
Market value
$11.20M
6/1/2026
Total
Units
160K
Value
$11.20M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/1/2026 | 160K | $11.20M | Nasdaq | Planned |
| Total | 160K | $11.20M | ||